Zydus Lifesciences Revises Buyback Terms Price Hiked to Rs 1260 Share Count Reduced Political Transition Struggles The Churn Reflects Resistance to Andy Burnhams Rise SpaceX Starship V3 Test Flight Scrubbed Rescheduled for Friday Your Bond Portfolio May Be Facing a Termite Infestation Worse Than Jamie Dimons Cockroaches Fiserv Pursues Constant Compounder Comeback with Clover AI and Banking Push GMR Solutions Inc Schedules First Quarter 2026 Earnings Conference Call CMSA Q1 2026 Earnings EPS Beats Estimates Amid Stable Utility Operations FIBK Q1 2026 Earnings EPS Miss Amid Tightening Bank Margins M Q1 2026 Earnings EPS Beats Estimates by 67 Amidst Ongoing Transformation BNR Q3 2022 Earnings Narrower Loss Surpasses Estimates Stock Declines Amphastar Pharmaceuticals AMPH Q1 2026 Earnings Significant EPS Miss Fails to Dampen Stock Sentiment Seabridge Gold Q1 2024 Earnings Net Loss per Share Reported Stock Edges Higher Tanger Inc SKT Edges Lower Testing Key Support Levels Amid Cautious Trading FTI Consulting FCN Edges Higher Near Resistance as Consolidation Pattern Emerges Goldman Sachs BDC Inc GSBD Holds Steady Near Support as Income Investors Eye Yield RF Acquisition Corp III Units RFAMU Hovers Near Support Amid Modest Uptick America Movil AMX Holds Above Key Support After Modest Decline Anthropics Olah Urges AI Governance Outside Big Tech Warns of LargeScale Labor Displacement OS Therapies OSTX Q4 2025 Earnings WiderThanExpected Loss Weighs on Shares Neumora Therapeutics NMRA Holds Steady at 185 as Stock Navigates Tight Range